Abstract
Whole-exome sequencing (WES) is an excellent method for the diagnosis of diseases of uncertain or heterogeneous genetic origin. However, it has limitations for detecting structural variations such as InDels, which the bioinformatics analyzers must be aware of. This study aimed at using WES to evaluate the genetic cause of the metabolic crisis in a 3-day-old neonate admitted to the neonatal intensive care unit (NICU) and deceased after a few days. Tandem mass spectrometry (MS/MS) showed a significant increase in propionyl carnitine (C3), proposing methylmalonic acidemia (MMA) or propionic acidemia (PA). WES demonstrated a homozygous missense variant in exon 4 of the BTD gene (NM_000060.4(BTD):c.1330G > C), responsible for partial biotinidase deficiency. Segregation analysis of the BTD variant revealed the homozygous status of the asymptomatic mother. Furthermore, observation of the bam file, around genes responsible for PA or MMA, by Integrative Genomics Viewer (IGV) software displayed a homozygous large deletion in the PCCA gene. Comprehensive confirmatory studies identified and segregated a novel outframe deletion of 217,877 bp length, “NG_008768.1:g.185211_403087delinsTA”, extended from intron 11 to 21 of the PCCA, inducing a premature termination codon and activation of nonsense-mediated mRNA decay (NMD). Homology modeling of the mutant PCCA demonstrated eliminating the protein's active site and critical functional domains. Thereupon, this novel variant is suggested as the largest deletion in the PCCA gene, causing an acute early-onset PA. These results could expand the PCCA variants spectrum, and improve the existing knowledge on the molecular basis of PA, as well as provide new evidence of pathogenicity of the variant (NM_000060.4(BTD):c.1330G > C.
Similar content being viewed by others
Data availability
The datasets analyzed during the WES and Primer sets are not publicly available because the individual privacy could be compromised, but they are available from the corresponding author upon reasonable request.
References
Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248–249
Ando T, Rasmussen K, Nyhan WL, Hull D (1972a) 3-hydroxypropionate: significance of -oxidation of propionate in patients with propionic acidemia and methylmalonic acidemia. Proc Natl Acad Sci U S A 69:2807–2811
Ando T, Rasmussen K, Wright JM, Nyhan WL (1972b) Isolation and identification of methylcitrate, a major metabolic product of propionate in patients with propionic acidemia. J Biol Chem 247:2200–2204
Arias C, Raimann E, Peredo P, Cabello JF, Castro G, Valiente A, de la Parra A, Bravo P, Okuma C, Cornejo V (2014) Propionic acidemia and optic neuropathy: a report of two cases. JIMD Rep 12:1–4
Baykal T, Gokcay G, Gokdemir Y, Demir F, Seckin Y, Demirkol M, Jensen K, Wolf B (2005) Asymptomatic adults and older siblings with biotinidase deficiency ascertained by family studies of index cases. J Inherit Metab Dis 28:903–912
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28:235–242
Cer RZ, Donohue DE, Mudunuri US, Temiz NA, Loss MA, Starner NJ, Halusa GN, Volfovsky N, Yi M, Luke BT, Bacolla A, Collins JR, Stephens RM (2013) Non-B DB v2.0: a database of predicted non-B DNA-forming motifs and its associated tools. Nucleic Acids Res 41:D94–D100
Davydov EV, Goode DL, Sirota M, Cooper GM, Sidow A, Batzoglou S (2010) Identifying a high fraction of the human genome to be under selective constraint using GERP++. PLoS Comput Biol 6:e1001025
Den Dunnen JT, Grootscholten PM, Bakker E, Blonden LA, Ginjaar HB, Wapenaar MC, van Paassen HM, van Broeckhoven C, Pearson PL, van Ommen GJ (1989) Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet 45:835–847
Desviat LR, Perez B, Perez-Cerda C, Rodriguez-Pombo P, Clavero S, Ugarte M (2004) Propionic acidemia: mutation update and functional and structural effects of the variant alleles. Mol Genet Metab 83:28–37
Desviat LR, Sanchez-Alcudia R, Perez B, Perez-Cerda C, Navarrete R, Vijzelaar R, Ugarte M (2009) High frequency of large genomic deletions in the PCCA gene causing propionic acidemia. Mol Genet Metab 96:171–176
Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL, McCarthy S, McVean GA, Abecasis GR (2015) A global reference for human genetic variation. Nature 526:68–74
Glusman G, Caballero J, Mauldin DE, Hood L, Roach JC (2011) Kaviar: an accessible system for testing SNV novelty. Bioinformatics 27:3216–3217
Hommes FA, Kuipers JR, Elema JD, Jansen JF, Jonxis JH (1968) Propionicacidemia, a new inborn error of metabolism. Pediatr Res 2:519–524
Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, Collins RL, Laricchia KM, Ganna A, Birnbaum DP, Gauthier LD, Brand H, Solomonson M, Watts NA, Rhodes D, Singer-Berk M, England EM, Seaby EG, Kosmicki JA, Walters RK, Tashman K, Farjoun Y, Banks E, Poterba T, Wang A, Seed C, Whiffin N, Chong JX, Samocha KE, Pierce-Hoffman E, Zappala Z, O’Donnell-Luria AH, Minikel EV, Weisburd B, Lek M, Ware JS, Vittal C, Armean IM, Bergelson L, Cibulskis K, Connolly KM, Covarrubias M, Donnelly S, Ferriera S, Gabriel S, Gentry J, Gupta N, Jeandet T, Kaplan D, Llanwarne C, Munshi R, Novod S, Petrillo N, Roazen D, Ruano-Rubio V, Saltzman A, Schleicher M, Soto J, Tibbetts K, Tolonen C, Wade G, Talkowski ME, Aguilar Salinas CA, Ahmad T, Albert CM, Ardissino D, Atzmon G, Barnard J, Beaugerie L, Benjamin EJ, Boehnke M, Bonnycastle LL, Bottinger EP, Bowden DW, Bown MJ, Chambers JC, Chan JC, Chasman D, Cho J, Chung MK, Cohen B, Correa A, Dabelea D, Daly MJ, Darbar D, Duggirala R, Dupuis J, Ellinor PT, Elosua R, Erdmann J, Esko T, Färkkilä M, Florez J, Franke A, Getz G, Glaser B, Glatt SJ, Goldstein D, Gonzalez C, Groop L, Haiman C, Hanis C, Harms M, Hiltunen M, Holi MM, Hultman CM, Kallela M, Kaprio J, Kathiresan S, Kim B-J, Kim YJ, Kirov G, Kooner J, Koskinen S, Krumholz HM, Kugathasan S, Kwak SH, Laakso M, Lehtimäki T, Loos RJF, Lubitz SA, Ma RCW, MacArthur DG, Marrugat J, Mattila KM, McCarroll S, McCarthy MI, McGovern D, McPherson R, Meigs JB, Melander O, Metspalu A, Neale BM, Nilsson PM, O’Donovan MC, Ongur D, Orozco L, Owen MJ, Palmer CNA, Palotie A, Park KS, Pato C, Pulver AE, Rahman N, Remes AM, Rioux JD, Ripatti S, Roden DM, Saleheen D, Salomaa V, Samani NJ, Scharf J, Schunkert H, Shoemaker MB, Sklar P, Soininen H, Sokol H, Spector T, Sullivan PF, Suvisaari J, Tai ES, Teo YY, Tiinamaija T, Tsuang M, Turner D, Tusie-Luna T, Vartiainen E, Vawter MP, Ware JS, Watkins H, Weersma RK, Wessman M, Wilson JG, Xavier RJ, Neale BM, Daly MJ, MacArthur DG, Genome Aggregation Database C (2020) The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581:434–443
Kaya N, Al-Owain M, Albakheet A, Colak D, Al-Odaib A, Imtiaz F, Coskun S, Al-Sayed M, Al-Hassnan Z, Al-Zaidan H, Meyer B, Ozand P (2008) Array comparative genomic hybridization (aCGH) reveals the largest novel deletion in PCCA found in a Saudi family with propionic acidemia. Eur J Med Genet 51:558–565
Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Albarca Aguilera M, Meyer R, Massouras A (2019) VarSome: the human genomic variant search engine. Bioinformatics 35:1978–1980
Kor D, Seker-Yilmaz B, Bulut FD, Kilavuz S, Oktem M, Ceylaner S, Yildizdas D, Onenli-Mungan N (2019) Clinical features of 27 Turkish Propionic acidemia patients with 12 novel mutations. Turk J Pediatr 61:330–336
Kraus JP, Spector E, Venezia S, Estes P, Chiang PW, Creadon-Swindell G, Mullerleile S, de Silva L, Barth M, Walter M, Walter K, Meissner T, Lindner M, Ensenauer R, Santer R, Bodamer OA, Baumgartner MR, Brunner-Krainz M, Karall D, Haase C, Knerr I, Marquardt T, Hennermann JB, Steinfeld R, Beblo S, Koch HG, Konstantopoulou V, Scholl-Burgi S, van Teeffelen-Heithoff A, Suormala T, Ugarte M, Sperl W, Superti-Furga A, Schwab KO, Grunert SC, Sass JO (2012) Mutation analysis in 54 propionic acidemia patients. J Inherit Metab Dis 35:51–63
Kurczynski TW, Hoppel CL, Goldblatt PJ, Gunning WT (1989) Metabolic studies of carnitine in a child with propionic acidemia. Pediatr Res 26:63–66
Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26:283–291
Li H, Durbin R (2010) Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26:589–595
Lord J, McMullan DJ, Eberhardt RY, Rinck G, Hamilton SJ, Quinlan-Jones E, Prigmore E, Keelagher R, Best SK, Carey GK, Mellis R, Robart S, Berry IR, Chandler KE, Cilliers D, Cresswell L, Edwards SL, Gardiner C, Henderson A, Holden ST, Homfray T, Lester T, Lewis RA, Newbury-Ecob R, Prescott K, Quarrell OW, Ramsden SC, Roberts E, Tapon D, Tooley MJ, Vasudevan PC, Weber AP, Wellesley DG, Westwood P, White H, Parker M, Williams D, Jenkins L, Scott RH, Kilby MD, Chitty LS, Hurles ME, Maher ER, Prenatal Assessment of G, Exomes C (2019) Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study. Lancet 393:747–757
Mohl A, Marschalek R, Masszi T, Nagy E, Obser T, Oyen F, Sallai K, Bodo I, Schneppenheim R (2008) An Alu-mediated novel large deletion is the most frequent cause of type 3 von Willebrand disease in Hungary. J Thromb Haemost 6:1729–1735
Norrgard KJ, Pomponio RJ, Hymes J, Wolf B (1999) Mutations causing profound biotinidase deficiency in children ascertained by newborn screening in the United States occur at different frequencies than in symptomatic children. Pediatr Res 46:20–27
Perez B, Desviat LR, Rodriguez-Pombo P, Clavero S, Navarrete R, Perez-Cerda C, Ugarte M (2003) Propionic acidemia: identification of twenty-four novel mutations in Europe and North America. Mol Genet Metab 78:59–67
Perez-Cerda C, Merinero B, Rodriguez-Pombo P, Perez B, Desviat LR, Muro S, Richard E, Garcia MJ, Gangoiti J, Ruiz Sala P, Sanz P, Briones P, Ribes A, Martinez-Pardo M, Campistol J, Perez M, Lama R, Murga ML, Lema-Garrett T, Verdu A, Ugarte M (2000) Potential relationship between genotype and clinical outcome in propionic acidaemia patients. Eur J Hum Genet 8:187–194
Pindolia K, Jordan M, Wolf B (2010) Analysis of mutations causing biotinidase deficiency. Hum Mutat 31:983–991
Popp MW, Maquat LE (2013) Organizing principles of mammalian nonsense-mediated mRNA decay. Annu Rev Genet 47:139–165
Porntaveetus T, Srichomthong C, Suphapeetiporn K, Shotelersuk V (2015) A novel PCCB mutation in a Thai patient with propionic acidemia identified by exome sequencing. Hum Genome Var 2:15033
Richard E, Desviat LR, Perez B, Perez-Cerda C, Ugarte M (1997) Three novel splice mutations in the PCCA gene causing identical exon skipping in propionic acidemia patients. Hum Genet 101:93–96
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, Committee ALQA (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424
Rivera-Barahona A, Navarrete R, Garcia-Rodriguez R, Richard E, Ugarte M, Perez-Cerda C, Perez B, Gamez A, Desviat LR (2018) Identification of 34 novel mutations in propionic acidemia: functional characterization of missense variants and phenotype associations. Mol Genet Metab 125:266–275
Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP (2011) Integrative genomics viewer. Nat Biotechnol 29:24–26
Schreiber J, Chapman KA, Summar ML, Ah Mew N, Sutton VR, MacLeod E, Stagni K, Ueda K, Franks J, Island E, Matern D, Pena L, Smith B, Urv T, Venditti C, Chakarapani A, Gropman AL (2012) Neurologic considerations in propionic acidemia. Mol Genet Metab 105:10–15
Schwarz JM, Cooper DN, Schuelke M, Seelow D (2014) MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 11:361–362
Sen SK, Han K, Wang J, Lee J, Wang H, Callinan PA, Dyer M, Cordaux R, Liang P, Batzer MA (2006) Human genomic deletions mediated by recombination between Alu elements. Am J Hum Genet 79:41–53
Swango KL, Demirkol M, Huner G, Pronicka E, Sykut-Cegielska J, Schulze A, Mayatepek E, Wolf B (1998) Partial biotinidase deficiency is usually due to the D444H mutation in the biotinidase gene. Hum Genet 102:571–575
Vaser R, Adusumalli S, Leng SN, Sikic M, Ng PC (2016) SIFT missense predictions for genomes. Nat Protoc 11:1–9
Wang K, Li M, Hakonarson H (2010) ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38:e164
Wang Y, Sun Y, Jiang T (2018) A novel PCCA mutation in a patient with late-onset propionic acidemia identified by genetic diagnosis panel. Front Pediatr 6:233
Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, Heer F, Beer T, Rempfer C, Bordoli L, Lepore A, Schwede T (2018) SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res 46:W296–W303
Wiederstein M, Sippl MJ (2007) ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 35:W407–W410
Wolf B (2010) Clinical issues and frequent questions about biotinidase deficiency. Mol Genet Metab 100:6–13
Wolf B, Norrgard K, Pomponio RJ, Mock DM, McVoy JR, Fleischhauer K, Shapiro S, Blitzer MG, Hymes J (1997) Profound biotinidase deficiency in two asymptomatic adults. Am J Med Genet 73:5–9
Wongkittichote P, Ah Mew N, Chapman KA (2017) Propionyl-CoA carboxylase - a review. Mol Genet Metab 122:145–152
Yang X, Sakamoto O, Matsubara Y, Kure S, Suzuki Y, Aoki Y, Yamaguchi S, Takahashi Y, Nishikubo T, Kawaguchi C, Yoshioka A, Kimura T, Hayasaka K, Kohno Y, Iinuma K, Ohura T (2004) Mutation spectrum of the PCCA and PCCB genes in Japanese patients with propionic acidemia. Mol Genet Metab 81:335–342
Yu J, Xie J, Luo L, Li Z (2014) An Alu element-mediated 28.5 kb alpha-thalassemia deletion found in a Chinese family. Hemoglobin 38:427–430
Zuker M (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31:3406–3415
Acknowledgements
The authors thank the patient's family for participation, the NICU section staff (academic members, fellowships, residents, and nurses) of Ali-Asghar Pediatrics hospital, Tehran, Iran, and Dr. Saman Nahid and the staff of Farzanegan metabolic laboratory, Shiraz, Iran, for their excellent collaboration.
Funding
This work was financially supported by “The Deputy of Research and Technology,” Pasteur Institute of Iran, Tehran, Iran, in partial fulfillment of the Ph.D. thesis of Mrs. Fereshteh Maryami under the supervision of Professor Sirous Zeinali.
Author information
Authors and Affiliations
Contributions
This is to certify that co-authors have had full access to the data in the present study and contributed to the decision to submit it for publication. Conceptualization: FM, ED-D, NK, ER, HR, ST, SZ. Methodology: FM, HR, ST, NK, SZ. Providing clinical data and clinical management: FM, NK, ST. Genetic counseling and sampling and consent: FM, ST, NK. WES and data analysis: FM, HR, ST, ED-D, ER, SZ. Homology modeling: FM, ER, HR. Variant’s interpretation of pathogenicity: FM, ST, ED-D, ER, HR, NK, SZ. Confirmatory tests interpretation and segregation analysis: FM, ED-D, ST, SZ. Writing—original draft preparation: FM, ER. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript. Editing: ED-D, ER, ST, HR, NK, SZ. Funding acquisition: SZ.
Corresponding authors
Ethics declarations
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial or non-financial interest in the subject matter or materials discussed in this manuscript.
Compliance with ethical standards
We confirm that we have reviewed the Journal policies detailed in the journal guide. Furthermore, we have read the Journal’s position on issues involved in ethical publications and affirm that this report is consistent with those guidelines.
Ethics approval
All investigations were established regarding the National Ethical Standards and approved by the Ethics Committee of the Pasteur Institute of Iran, Tehran, Iran, with the approval code of I.R.PII.REC.1397.70. We confirm that we have reviewed the Journal policies detailed in the journal guide. Furthermore, we have read the Journal's position on issues involved in ethical publications and affirm that this report is consistent with those guidelines.
Consent to participate
The authors affirm that written informed consent was obtained from the parents for their participation.
Consent to publish
The authors also affirm that the parents were given written informed consent to publish the pertinent data included in this article.
Additional information
Communicated by Shuhua Xu.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Maryami, F., Davoudi-Dehaghani, E., Khalesi, N. et al. Identification and characterization of the largest deletion in the PCCA gene causing severe acute early-onset form of propionic acidemia. Mol Genet Genomics 298, 905–917 (2023). https://doi.org/10.1007/s00438-023-02023-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00438-023-02023-3